Epidemiology of Hirsutism Among Women of Reproductive Age in the Community: A Simplified Scoring System

    Rong Li, Jie Qiao, Dongzi Yang, Shangwei Li, Shulan Lu, Xiaoke Wu, Zhaolian Wei
    Image of study
    TLDR A simplified scoring system can effectively diagnose hirsutism in Chinese women of reproductive age.
    In a study involving 10,120 Chinese women of reproductive age, researchers found that a simplified scoring system using the modified Ferriman-Galwey (mF-G) method could effectively diagnose hirsutism. They determined that a score greater than 4 should be used for diagnosis in this population, with a focus on hair growth on the upper lip, thighs, and lower abdomen. A cut-off value of 2 for these areas yielded a high sensitivity of 98.7% and specificity of 91.0%. The study also observed that the prevalence of hirsutism and the average mF-G score decreased with age. This large-scale epidemiological study suggests that the diagnostic criteria for hirsutism may need to be adjusted for different age groups and provides a simplified method for clinical evaluation.
    Discuss this study in the Community →

    Research cited in this study

    12 / 12 results

    Related Community Posts Join

    6 / 25 results

      community AA and Hirsutism but T levels are normal

      in Female  8 upvotes 3 years ago
      27-year-old female experiences aggressive hair thinning and hirsutism despite normal testosterone levels. Spironolactone and 2% minoxidil were ineffective; high DHEA sulfate levels may be the cause.
      [object Object]

      community Finasteride 5mg & Spironolactone 100mg

      in Female  2 upvotes 1 month ago
      A 20-year-old female is using finasteride 5mg and spironolactone 100mg for severe hirsutism and is experiencing minor side effects like water weight loss and irregular periods. She is concerned about potential future side effects and hair regrowth on her scalp.

      community No, Finasteride as a treatment for MPB was not an "accident"

      in Research/Science  105 upvotes 3 years ago
      Finasteride was intentionally developed to treat BPH and later approved for male pattern baldness (MPB) due to its 5AR inhibition effects. The delay in MPB approval was due to concerns about off-label use for female hirsutism and the prioritization of treating a more debilitating condition.

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  117 upvotes 4 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

      community Does low HGH leading to hairloss?

      in Research/Science  13 upvotes 11 months ago
      The user experiencing diffuse hair loss is using various treatments including RU58841, finasteride, minoxidil with tretinoin, anti-hair loss shampoo, and microneedling, and is considering adding peptides TB500, BPC157, and GHK-Cu. They have low growth hormone levels and are questioning its impact on hair loss, while another user suggests androgenic alopecia and androgens are likely the main cause of hair loss.

    Related Research

    1 / 1 results